Elicio Therapeutics, Inc. (ELTX) Executive Compensation
Elicio Therapeutics, Inc. (ELTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ELTX
CIK: 1601485
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerKristen Godsoe
Audit LocationTewksbury, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEF 14A | 2026-10-09 | 2025-12-31 | DEF 14A | 0001601485-26-000061 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001601485-26-000058 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001230486-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001761748-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001979324-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001441889-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001187308-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001267490-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | FORM 4 | 0001413350-26-000009 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001601485-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001601485-26-000055 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001612095-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001979163-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001787403-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-16 | FORM 4 | 0001796436-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-16 | — | SCHEDULE 13G Filing | 0002145902-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001104659-26-081751 | View SEC Doc Filr Page |
| 424B5 | 2026-07-02 | — | 424B5 | 0001104659-26-080106 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-01 | FORM 8-K | 0001104659-26-080058 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001601485-26-000050 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001601485-26-000048 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001601485-26-000046 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | 10-Q | 0001601485-26-000042 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001601485-26-000041 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-29 | 2025-12-31 | 10-K/A | 0001601485-26-000035 | View SEC Doc Filr Page |